Skip to content

anti-pruritic effrcts of curcumin on refractory burn itching

Evaluation of anti-pruritic effects of curcumin in treatment resistant burn patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170609034406N7
Enrollment
100
Registered
2021-05-14
Start date
2021-06-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn pruritus. Other pruritus

Interventions

Intervention 1: Intervention group:Intervention group (curcumin recipient) includes 50 patients who will receive two capsules of curcumin ( 40mg activing redient in each capsule ) daily by mouth for 3

Sponsors

Ardabil University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years ; Having itching after burn injury ; Ability to understand and sign consent form

Exclusion criteria

Exclusion criteria: Other causes of pruritus including renal failure ; Pregnancy; presence of any chronic active, uncontrolled or severe inflammatory disease ( such as autoimmune diseases, connective tissue disease, malignancy, HIV, liver disease and pulmonary disease) ;Breastfeeding ; involvement in other clinical trials ; malabsorption syndrome ; Bleeding disorders ( Including coagulopathies) or high risk for bleeding ;intake of a curcumin supplement or other supplements that affecting itching such as omega_3 in the recent month ; Intolerance or allergy to curcumin ; Receiving drugs that have an effect on inflammatory factors ( sach as corticosteroids or other immunosuppressive drugs, non-steroidal anti-inflammatory drugs, pentoxifylline) in the recent 6 weeks; Use of warfarin ; Abuse of alcohol and other substances that cause dependence.

Design outcomes

Primary

MeasureTime frame
Pruritus score. Timepoint: Before starting the intervention, Six weeks after the intervention and at the end of the intervention period. Method of measurement: Standard questionnaire.

Secondary

MeasureTime frame
Quality of life. Timepoint: Before starting the intervention, Six weeks after the intervention and at the end of the intervention. Method of measurement: Standard questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfshin Gharekhani

Tabriz University of Medical Sciences

anqarekhani@yahoo.com+98 41 3230 5351

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026